Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
Boston Scientific (BSX) Rides on Emerging Markets, MedSurg
11:06am, Thursday, 23'rd May 2024
Boston Scientific's (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and pulmonary treatment options.
What Drove A Nearly 2x Rise In Boston Scientific's Profits?
05:45am, Wednesday, 22'nd May 2024
Boston Scientific Boston Scientific (NYSE: BSX) saw its net income expand by $0.9 billion or 145% y-o-y to $1.6 billion in 2023. This can primarily be attributed to an expansion of its operating margi
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
02:21pm, Monday, 20'th May 2024
Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.
Boston Scientific (BSX) mCRM System Study Outcome Favorable
12:00am, Monday, 20'th May 2024
Boston Scientific Corporation (BSX Quick QuoteBSX - Free Report) recently presented favorable six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM System — the first mod
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
11:03am, Saturday, 18'th May 2024
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker MARLBOROUGH, Mass. , May 18, 2024 /PR
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Boston Scientific Corporation (NYSE:BSX)
3 Solid Buys From MedTech Following 2024 Guidance Raise
10:45am, Wednesday, 15'th May 2024
Guidance hikes by BSX, ALGN and ALC for 2024 make them attractive investment bets.
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?
10:32am, Wednesday, 15'th May 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts
01:16pm, Tuesday, 14'th May 2024
Within Neuromodulation, Boston Scientific's pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Boston Scientific Corporation (NYSE:BSX)
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors
04:00pm, Wednesday, 08'th May 2024
MARLBOROUGH, Mass. , May 8, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immediately.
NEW YORK, NY / ACCESSWIRE / May 7, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Boston Scientific Corporation (NYSE:BSX).
A Golden Opportunity to Enter U.S. Stock Markets: 5 Top Picks
09:31am, Monday, 06'th May 2024
We have narrowed our search to five U.S. corporate behemoths that have strong growth potential for 2024. These are: GOOGL, NFLX, AMZN, NOW, BSX.
Citi Just Raised Its Price Target on These 3 Stocks
06:15am, Saturday, 04'th May 2024
Many Wall Street investors keep a close eye on the opinions of major brokerages, such as Citigroup (NYSE: C ). Therefore, today we'll explore three promising growth stocks that have recently received
NEW YORK, NY / ACCESSWIRE / May 2, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Boston Scientific Corporation (NYSE:BSX).
